Abstract
The original study was conducted to study the prevalence and incidence of the neuropathic component of chronic pain in patients with malignant neoplasms. The cohort study sample was formed in the Regional Oncology Dispensary of Karaganda. The study included 374 cancer patients. Neuropathic chronic pain of varying intensity and localization was diagnosed in 106 patients. The sample patients were divided into the main and control groups using the envelope method. Each group was analyzed in detail, the main clinical characteristics of each patient were described. Gender, age, localization and prevalence of the primary focus of malignant neoplasm, and the type of antitumor treatment were analyzed. The original study found that the neuropathic component of chronic pain is more common in women over 50 years of age. In the vast majority of cases, such patients are diagnosed with stage III breast cancer who have undergone complex or combined treatment. Given the identified cohort of patients who develop chronic neuropathic pain, it is possible to begin preventive measures earlier. These measures will reduce the burden of developing a difficult-to-treat type of chronic pain among cancer patients.